nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—CYP2D6—endogenous depression	0.667	1	CbGaD
Procainamide—Moclobemide—MAOA—endogenous depression	0.00334	0.506	CrCbGaD
Procainamide—SCN8A—brainstem—endogenous depression	0.00311	0.0201	CbGeAlD
Procainamide—SCN8A—forebrain—endogenous depression	0.00301	0.0194	CbGeAlD
Procainamide—SCN7A—cardiovascular system—endogenous depression	0.00285	0.0184	CbGeAlD
Procainamide—DNMT1—forebrain—endogenous depression	0.00259	0.0167	CbGeAlD
Procainamide—DNMT1—adrenal cortex—endogenous depression	0.0024	0.0155	CbGeAlD
Procainamide—SCN1A—brainstem—endogenous depression	0.00235	0.0152	CbGeAlD
Procainamide—SCN1A—forebrain—endogenous depression	0.00227	0.0147	CbGeAlD
Procainamide—SCN7A—adrenal gland—endogenous depression	0.00226	0.0146	CbGeAlD
Procainamide—DNMT1—cardiovascular system—endogenous depression	0.00219	0.0141	CbGeAlD
Procainamide—SCN7A—thyroid gland—endogenous depression	0.00218	0.0141	CbGeAlD
Procainamide—SCN2A—brainstem—endogenous depression	0.00216	0.014	CbGeAlD
Procainamide—SCN11A—nervous system—endogenous depression	0.00215	0.0139	CbGeAlD
Procainamide—SCN2A—forebrain—endogenous depression	0.00209	0.0135	CbGeAlD
Procainamide—SCN11A—central nervous system—endogenous depression	0.00207	0.0134	CbGeAlD
Procainamide—SCN10A—forebrain—endogenous depression	0.00201	0.013	CbGeAlD
Procainamide—SCN9A—L1CAM interactions—ANK3—endogenous depression	0.00201	0.0117	CbGpPWpGaD
Procainamide—SCN9A—pituitary gland—endogenous depression	0.00198	0.0128	CbGeAlD
Procainamide—SCN7A—endocrine gland—endogenous depression	0.00196	0.0126	CbGeAlD
Procainamide—DNMT1—pituitary gland—endogenous depression	0.00194	0.0125	CbGeAlD
Procainamide—SCN3A—L1CAM interactions—ANK3—endogenous depression	0.00192	0.0112	CbGpPWpGaD
Procainamide—SCN4A—L1CAM interactions—ANK3—endogenous depression	0.00185	0.0108	CbGpPWpGaD
Procainamide—SCN2A—L1CAM interactions—ANK3—endogenous depression	0.00185	0.0108	CbGpPWpGaD
Procainamide—SCN3A—forebrain—endogenous depression	0.00183	0.0118	CbGeAlD
Procainamide—ACHE—Biogenic Amine Synthesis—COMT—endogenous depression	0.00179	0.0104	CbGpPWpGaD
Procainamide—SCN10A—L1CAM interactions—ANK3—endogenous depression	0.00178	0.0104	CbGpPWpGaD
Procainamide—SCN1A—L1CAM interactions—ANK3—endogenous depression	0.00178	0.0104	CbGpPWpGaD
Procainamide—ACHE—Biogenic Amine Synthesis—MAOA—endogenous depression	0.00178	0.0104	CbGpPWpGaD
Procainamide—SCN9A—adrenal gland—endogenous depression	0.00177	0.0114	CbGeAlD
Procainamide—SCN4A—pituitary gland—endogenous depression	0.00176	0.0114	CbGeAlD
Procainamide—SCN9A—midbrain—endogenous depression	0.00174	0.0113	CbGeAlD
Procainamide—SCN8A—endocrine gland—endogenous depression	0.00174	0.0113	CbGeAlD
Procainamide—DNMT1—adrenal gland—endogenous depression	0.00173	0.0112	CbGeAlD
Procainamide—DNMT1—midbrain—endogenous depression	0.00171	0.011	CbGeAlD
Procainamide—DNMT1—thyroid gland—endogenous depression	0.00167	0.0108	CbGeAlD
Procainamide—SCN11A—brain—endogenous depression	0.00165	0.0106	CbGeAlD
Procainamide—SCN8A—nervous system—endogenous depression	0.00163	0.0105	CbGeAlD
Procainamide—ACHE—Monoamine Transport—TPH2—endogenous depression	0.00161	0.00941	CbGpPWpGaD
Procainamide—SCN4A—adrenal gland—endogenous depression	0.00158	0.0102	CbGeAlD
Procainamide—SCN8A—central nervous system—endogenous depression	0.00157	0.0101	CbGeAlD
Procainamide—SCN2A—pituitary gland—endogenous depression	0.00156	0.0101	CbGeAlD
Procainamide—CHRM2—forebrain—endogenous depression	0.00156	0.01	CbGeAlD
Procainamide—SCN5A—cardiovascular system—endogenous depression	0.00155	0.00998	CbGeAlD
Procainamide—SCN8A—cerebellum—endogenous depression	0.00154	0.00992	CbGeAlD
Procainamide—SLC22A1—forebrain—endogenous depression	0.00153	0.00987	CbGeAlD
Procainamide—SCN4A—thyroid gland—endogenous depression	0.00152	0.00982	CbGeAlD
Procainamide—Moclobemide—CYP2D6—endogenous depression	0.00151	0.229	CrCbGaD
Procainamide—SCN10A—pituitary gland—endogenous depression	0.00151	0.00972	CbGeAlD
Procainamide—DNMT1—endocrine gland—endogenous depression	0.0015	0.0097	CbGeAlD
Procainamide—SCN1A—midbrain—endogenous depression	0.0015	0.00969	CbGeAlD
Procainamide—ACHE—adrenal gland—endogenous depression	0.00141	0.00909	CbGeAlD
Procainamide—DNMT1—nervous system—endogenous depression	0.00141	0.00908	CbGeAlD
Procainamide—SCN7A—brain—endogenous depression	0.0014	0.00904	CbGeAlD
Procainamide—ACHE—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.00139	0.00814	CbGpPWpGaD
Procainamide—ACHE—midbrain—endogenous depression	0.00139	0.00898	CbGeAlD
Procainamide—SCN2A—midbrain—endogenous depression	0.00138	0.00889	CbGeAlD
Procainamide—SCN3A—pituitary gland—endogenous depression	0.00137	0.00886	CbGeAlD
Procainamide—ACHE—thyroid gland—endogenous depression	0.00136	0.00877	CbGeAlD
Procainamide—DNMT1—central nervous system—endogenous depression	0.00135	0.00874	CbGeAlD
Procainamide—DNMT1—cerebellum—endogenous depression	0.00132	0.00855	CbGeAlD
Procainamide—CHRM2—cardiovascular system—endogenous depression	0.00132	0.0085	CbGeAlD
Procainamide—ACHE—Monoamine Transport—SLC6A4—endogenous depression	0.00129	0.00752	CbGpPWpGaD
Procainamide—SCN4A—nervous system—endogenous depression	0.00128	0.00826	CbGeAlD
Procainamide—SCN5A—L1CAM interactions—ANK3—endogenous depression	0.00125	0.0073	CbGpPWpGaD
Procainamide—SCN8A—brain—endogenous depression	0.00125	0.00805	CbGeAlD
Procainamide—SCN1A—nervous system—endogenous depression	0.00123	0.00797	CbGeAlD
Procainamide—SCN4A—central nervous system—endogenous depression	0.00123	0.00795	CbGeAlD
Procainamide—SCN3A—adrenal gland—endogenous depression	0.00123	0.00792	CbGeAlD
Procainamide—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—endogenous depression	0.00122	0.00714	CbGpPWpGaD
Procainamide—SCN3A—midbrain—endogenous depression	0.00121	0.00782	CbGeAlD
Procainamide—SCN2A—endocrine gland—endogenous depression	0.00121	0.00781	CbGeAlD
Procainamide—SLC22A4—pituitary gland—endogenous depression	0.0012	0.00776	CbGeAlD
Procainamide—SCN1A—central nervous system—endogenous depression	0.00119	0.00767	CbGeAlD
Procainamide—SCN3A—thyroid gland—endogenous depression	0.00118	0.00764	CbGeAlD
Procainamide—SCN10A—endocrine gland—endogenous depression	0.00117	0.00753	CbGeAlD
Procainamide—SCN1A—cerebellum—endogenous depression	0.00116	0.0075	CbGeAlD
Procainamide—SCN7A—Axon guidance—ANK3—endogenous depression	0.00115	0.00672	CbGpPWpGaD
Procainamide—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—endogenous depression	0.00114	0.00666	CbGpPWpGaD
Procainamide—SCN2A—nervous system—endogenous depression	0.00113	0.00731	CbGeAlD
Procainamide—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—endogenous depression	0.00113	0.00658	CbGpPWpGaD
Procainamide—SCN9A—brain—endogenous depression	0.0011	0.00708	CbGeAlD
Procainamide—SCN10A—nervous system—endogenous depression	0.00109	0.00705	CbGeAlD
Procainamide—SCN2A—central nervous system—endogenous depression	0.00109	0.00704	CbGeAlD
Procainamide—ACHE—cerebellum—endogenous depression	0.00108	0.00694	CbGeAlD
Procainamide—DNMT1—brain—endogenous depression	0.00108	0.00694	CbGeAlD
Procainamide—SLC22A4—adrenal gland—endogenous depression	0.00107	0.00693	CbGeAlD
Procainamide—BCHE—brainstem—endogenous depression	0.00107	0.00692	CbGeAlD
Procainamide—SCN2A—cerebellum—endogenous depression	0.00107	0.00688	CbGeAlD
Procainamide—SCN10A—central nervous system—endogenous depression	0.00105	0.00679	CbGeAlD
Procainamide—ACHE—Melatonin metabolism and effects—MAOA—endogenous depression	0.00105	0.00612	CbGpPWpGaD
Procainamide—SLC22A4—thyroid gland—endogenous depression	0.00104	0.00669	CbGeAlD
Procainamide—BCHE—forebrain—endogenous depression	0.00103	0.00668	CbGeAlD
Procainamide—SCN11A—Axon guidance—ANK3—endogenous depression	0.00103	0.00599	CbGpPWpGaD
Procainamide—SCN3A—nervous system—endogenous depression	0.000995	0.00643	CbGeAlD
Procainamide—SCN5A—nervous system—endogenous depression	0.000992	0.00641	CbGeAlD
Procainamide—SLC22A5—adrenal cortex—endogenous depression	0.000984	0.00636	CbGeAlD
Procainamide—SCN4A—brain—endogenous depression	0.000978	0.00631	CbGeAlD
Procainamide—SLC22A3—adrenal gland—endogenous depression	0.000977	0.00631	CbGeAlD
Procainamide—Metoclopramide—CYP2D6—endogenous depression	0.000975	0.148	CrCbGaD
Procainamide—SCN3A—central nervous system—endogenous depression	0.000958	0.00619	CbGeAlD
Procainamide—SCN5A—central nervous system—endogenous depression	0.000955	0.00617	CbGeAlD
Procainamide—SCN1A—brain—endogenous depression	0.000943	0.00609	CbGeAlD
Procainamide—SLC22A3—thyroid gland—endogenous depression	0.000943	0.00609	CbGeAlD
Procainamide—SCN8A—Axon guidance—ANK3—endogenous depression	0.000939	0.00548	CbGpPWpGaD
Procainamide—SCN3A—cerebellum—endogenous depression	0.000936	0.00605	CbGeAlD
Procainamide—CHRM2—endocrine gland—endogenous depression	0.000903	0.00583	CbGeAlD
Procainamide—SLC22A1—endocrine gland—endogenous depression	0.000887	0.00572	CbGeAlD
Procainamide—CHRM2—Monoamine GPCRs—HTR1A—endogenous depression	0.000885	0.00516	CbGpPWpGaD
Procainamide—BCHE—cardiovascular system—endogenous depression	0.000875	0.00565	CbGeAlD
Procainamide—ACHE—brain—endogenous depression	0.000873	0.00564	CbGeAlD
Procainamide—SCN2A—brain—endogenous depression	0.000865	0.00559	CbGeAlD
Procainamide—CHRM2—Monoamine GPCRs—HTR2C—endogenous depression	0.000855	0.00498	CbGpPWpGaD
Procainamide—SLC22A3—endocrine gland—endogenous depression	0.000847	0.00547	CbGeAlD
Procainamide—CHRM2—nervous system—endogenous depression	0.000845	0.00545	CbGeAlD
Procainamide—SCN10A—brain—endogenous depression	0.000835	0.00539	CbGeAlD
Procainamide—SLC22A1—nervous system—endogenous depression	0.00083	0.00536	CbGeAlD
Procainamide—SCN7A—Developmental Biology—ANK3—endogenous depression	0.000822	0.00479	CbGpPWpGaD
Procainamide—SLC22A4—cerebellum—endogenous depression	0.00082	0.00529	CbGeAlD
Procainamide—CHRM2—central nervous system—endogenous depression	0.000813	0.00525	CbGeAlD
Procainamide—SCN7A—Axon guidance—CACNB2—endogenous depression	0.000812	0.00473	CbGpPWpGaD
Procainamide—SLC22A1—central nervous system—endogenous depression	0.000799	0.00516	CbGeAlD
Procainamide—SLC22A5—pituitary gland—endogenous depression	0.000795	0.00514	CbGeAlD
Procainamide—SLC22A3—nervous system—endogenous depression	0.000793	0.00512	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000789	0.0046	CbGpPWpGaD
Procainamide—BCHE—pituitary gland—endogenous depression	0.000775	0.005	CbGeAlD
Procainamide—Lidocaine—CYP2D6—endogenous depression	0.000774	0.117	CrCbGaD
Procainamide—SLC22A3—central nervous system—endogenous depression	0.000764	0.00493	CbGeAlD
Procainamide—SCN3A—brain—endogenous depression	0.000761	0.00491	CbGeAlD
Procainamide—SCN9A—Axon guidance—ANK3—endogenous depression	0.000759	0.00443	CbGpPWpGaD
Procainamide—SCN5A—brain—endogenous depression	0.000758	0.0049	CbGeAlD
Procainamide—CHRM2—Monoamine GPCRs—HTR7—endogenous depression	0.000748	0.00437	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000744	0.00434	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—CACNA1C—endogenous depression	0.000742	0.00433	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—ANK3—endogenous depression	0.000733	0.00427	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—ANK3—endogenous depression	0.000726	0.00424	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—CACNB2—endogenous depression	0.000723	0.00422	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000718	0.00419	CbGpPWpGaD
Procainamide—SLC22A5—adrenal gland—endogenous depression	0.00071	0.00459	CbGeAlD
Procainamide—CYP2D6—brainstem—endogenous depression	0.00071	0.00459	CbGeAlD
Procainamide—SLC22A5—midbrain—endogenous depression	0.000701	0.00453	CbGeAlD
Procainamide—SCN2A—Axon guidance—ANK3—endogenous depression	0.000698	0.00407	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—ANK3—endogenous depression	0.000698	0.00407	CbGpPWpGaD
Procainamide—BCHE—adrenal gland—endogenous depression	0.000692	0.00447	CbGeAlD
Procainamide—SLC22A5—thyroid gland—endogenous depression	0.000686	0.00443	CbGeAlD
Procainamide—CYP2D6—forebrain—endogenous depression	0.000685	0.00443	CbGeAlD
Procainamide—BCHE—midbrain—endogenous depression	0.000683	0.00441	CbGeAlD
Procainamide—SCN1A—Axon guidance—ANK3—endogenous depression	0.000673	0.00393	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—ANK3—endogenous depression	0.000673	0.00393	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—ANK3—endogenous depression	0.00067	0.00391	CbGpPWpGaD
Procainamide—BCHE—thyroid gland—endogenous depression	0.000668	0.00431	CbGeAlD
Procainamide—SLC22A4—brain—endogenous depression	0.000666	0.0043	CbGeAlD
Procainamide—SCN8A—Axon guidance—CACNB2—endogenous depression	0.000662	0.00386	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—CACNA1C—endogenous depression	0.000662	0.00386	CbGpPWpGaD
Procainamide—CHRM2—brain—endogenous depression	0.000646	0.00417	CbGeAlD
Procainamide—SLC22A1—brain—endogenous depression	0.000634	0.0041	CbGeAlD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR7—endogenous depression	0.000629	0.00367	CbGpPWpGaD
Procainamide—SLC22A2—Neurotransmitter Release Cycle—MAOA—endogenous depression	0.000622	0.00363	CbGpPWpGaD
Procainamide—SLC22A3—brain—endogenous depression	0.000606	0.00391	CbGeAlD
Procainamide—SCN8A—Axon guidance—CACNA1C—endogenous depression	0.000605	0.00353	CbGpPWpGaD
Procainamide—BCHE—endocrine gland—endogenous depression	0.0006	0.00387	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000598	0.00349	CbGpPWpGaD
Procainamide—SLC22A1—Neurotransmitter Release Cycle—MAOA—endogenous depression	0.00058	0.00338	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CACNB2—endogenous depression	0.000579	0.00338	CbGpPWpGaD
Procainamide—BCHE—nervous system—endogenous depression	0.000562	0.00363	CbGeAlD
Procainamide—SLC22A5—cerebellum—endogenous depression	0.000543	0.0035	CbGeAlD
Procainamide—SCN9A—Developmental Biology—ANK3—endogenous depression	0.000542	0.00316	CbGpPWpGaD
Procainamide—BCHE—central nervous system—endogenous depression	0.000541	0.00349	CbGeAlD
Procainamide—SCN9A—Axon guidance—CACNB2—endogenous depression	0.000535	0.00312	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CACNA1C—endogenous depression	0.00053	0.00309	CbGpPWpGaD
Procainamide—BCHE—cerebellum—endogenous depression	0.000528	0.00341	CbGeAlD
Procainamide—CHRM2—Monoamine GPCRs—HTR2A—endogenous depression	0.000524	0.00306	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—ANK3—endogenous depression	0.000518	0.00302	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CACNB2—endogenous depression	0.000516	0.00301	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—CACNB2—endogenous depression	0.000512	0.00299	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—ANK3—endogenous depression	0.000498	0.0029	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—ANK3—endogenous depression	0.000498	0.0029	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000495	0.00289	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—CACNB2—endogenous depression	0.000492	0.00287	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—CACNB2—endogenous depression	0.000492	0.00287	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—CACNA1C—endogenous depression	0.000489	0.00285	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—ANK3—endogenous depression	0.00048	0.0028	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—ANK3—endogenous depression	0.00048	0.0028	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000478	0.00279	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000478	0.00279	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—CACNB2—endogenous depression	0.000474	0.00277	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—CACNB2—endogenous depression	0.000474	0.00277	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—ANK3—endogenous depression	0.000473	0.00276	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CACNA1C—endogenous depression	0.000472	0.00275	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CACNB2—endogenous depression	0.000472	0.00275	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—CACNA1C—endogenous depression	0.000468	0.00273	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—CACNA1C—endogenous depression	0.00045	0.00262	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—CACNA1C—endogenous depression	0.00045	0.00262	CbGpPWpGaD
Procainamide—SLC22A5—brain—endogenous depression	0.000441	0.00285	CbGeAlD
Procainamide—CHRM2—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000441	0.00257	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—CACNA1C—endogenous depression	0.000434	0.00253	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—CACNA1C—endogenous depression	0.000434	0.00253	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CACNA1C—endogenous depression	0.000432	0.00252	CbGpPWpGaD
Procainamide—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000431	0.00251	CbGpPWpGaD
Procainamide—BCHE—brain—endogenous depression	0.000429	0.00277	CbGeAlD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000407	0.00237	CbGpPWpGaD
Procainamide—CYP2D6—endocrine gland—endogenous depression	0.000398	0.00257	CbGeAlD
Procainamide—SCN9A—Developmental Biology—CACNB2—endogenous depression	0.000382	0.00223	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000372	0.00217	CbGpPWpGaD
Procainamide—CYP2D6—nervous system—endogenous depression	0.000372	0.0024	CbGeAlD
Procainamide—SCN3A—Developmental Biology—CACNB2—endogenous depression	0.000365	0.00213	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00036	0.0021	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.000359	0.00209	CbGpPWpGaD
Procainamide—CYP2D6—central nervous system—endogenous depression	0.000358	0.00231	CbGeAlD
Procainamide—SCN2A—Developmental Biology—CACNB2—endogenous depression	0.000351	0.00205	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CACNB2—endogenous depression	0.000351	0.00205	CbGpPWpGaD
Procainamide—CYP2D6—cerebellum—endogenous depression	0.00035	0.00226	CbGeAlD
Procainamide—SCN9A—Developmental Biology—CACNA1C—endogenous depression	0.000349	0.00204	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000347	0.00203	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.000344	0.00201	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CACNB2—endogenous depression	0.000338	0.00197	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CACNB2—endogenous depression	0.000338	0.00197	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—ANK3—endogenous depression	0.000338	0.00197	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CACNA1C—endogenous depression	0.000334	0.00195	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—CACNB2—endogenous depression	0.000333	0.00194	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—HTR7—endogenous depression	0.000332	0.00194	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000332	0.00194	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000331	0.00193	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CACNA1C—endogenous depression	0.000321	0.00187	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CACNA1C—endogenous depression	0.000321	0.00187	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CACNA1C—endogenous depression	0.000309	0.0018	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CACNA1C—endogenous depression	0.000309	0.0018	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000309	0.0018	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000307	0.00179	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—CACNA1C—endogenous depression	0.000305	0.00178	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000297	0.00173	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000293	0.00171	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.000293	0.00171	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—POMC—endogenous depression	0.000289	0.00169	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CACNB2—endogenous depression	0.000285	0.00166	CbGpPWpGaD
Procainamide—CYP2D6—brain—endogenous depression	0.000284	0.00184	CbGeAlD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000276	0.00161	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—POMC—endogenous depression	0.000258	0.0015	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000255	0.00149	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CACNB2—endogenous depression	0.000254	0.00148	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000247	0.00144	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000247	0.00144	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CACNB2—endogenous depression	0.000238	0.00139	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—HTR2A—endogenous depression	0.000233	0.00136	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CACNB2—endogenous depression	0.000227	0.00133	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—COMT—endogenous depression	0.000226	0.00132	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000224	0.00131	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000224	0.00131	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CACNA1C—endogenous depression	0.000218	0.00127	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CACNB2—endogenous depression	0.000212	0.00124	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—COMT—endogenous depression	0.000201	0.00117	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—MAOA—endogenous depression	0.0002	0.00117	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000195	0.00114	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000186	0.00108	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—HTR1A—endogenous depression	0.000184	0.00107	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—COMT—endogenous depression	0.00018	0.00105	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000179	0.00104	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000178	0.00104	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—COMT—endogenous depression	0.000173	0.00101	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—MAOA—endogenous depression	0.000172	0.001	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000171	0.000997	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000171	0.000996	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—COMT—endogenous depression	0.000167	0.000977	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000166	0.00097	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000165	0.000962	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000158	0.000923	CbGpPWpGaD
Procainamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000157	0.000914	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—COMT—endogenous depression	0.000154	0.000899	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—MAOA—endogenous depression	0.000153	0.000893	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000152	0.000886	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000151	0.000882	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000146	0.000853	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000144	0.000842	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000141	0.000824	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADM—endogenous depression	0.000138	0.000806	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—COMT—endogenous depression	0.000138	0.000803	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MAOA—endogenous depression	0.000137	0.000797	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—COMT—endogenous depression	0.000128	0.000749	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MAOA—endogenous depression	0.000127	0.000743	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000127	0.000741	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000124	0.000722	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TPH1—endogenous depression	0.00012	0.000702	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CRH—endogenous depression	0.000116	0.000675	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—OXT—endogenous depression	0.000116	0.000675	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NR3C1—endogenous depression	0.000115	0.000671	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1A—endogenous depression	0.000111	0.00065	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2C—endogenous depression	0.000108	0.000628	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—COMT—endogenous depression	0.000104	0.000609	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—MAOA—endogenous depression	0.000104	0.000604	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	0.000103	0.0006	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000101	0.00059	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPH1—endogenous depression	9.48e-05	0.000553	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR7—endogenous depression	9.42e-05	0.00055	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TPH2—endogenous depression	9.12e-05	0.000532	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CACNB2—endogenous depression	9.12e-05	0.000532	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—DPYD—endogenous depression	8.98e-05	0.000524	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—endogenous depression	8.71e-05	0.000508	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	8.67e-05	0.000506	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPH1—endogenous depression	8.46e-05	0.000493	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CACNA1C—endogenous depression	8.35e-05	0.000487	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADM—endogenous depression	7.8e-05	0.000455	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPH1—endogenous depression	7.55e-05	0.00044	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP2D6—endogenous depression	7.29e-05	0.000425	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPH2—endogenous depression	7.18e-05	0.000419	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CACNB2—endogenous depression	7.18e-05	0.000419	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADM—endogenous depression	7.09e-05	0.000413	CbGpPWpGaD
Procainamide—ACHE—Metabolism—DPYD—endogenous depression	7.07e-05	0.000412	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPH1—endogenous depression	7.04e-05	0.000411	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.92e-05	0.000404	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—endogenous depression	6.75e-05	0.000394	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2A—endogenous depression	6.6e-05	0.000385	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CACNA1C—endogenous depression	6.57e-05	0.000383	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CRH—endogenous depression	6.54e-05	0.000381	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OXT—endogenous depression	6.54e-05	0.000381	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPH2—endogenous depression	6.41e-05	0.000374	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CACNB2—endogenous depression	6.41e-05	0.000374	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—endogenous depression	6.32e-05	0.000368	CbGpPWpGaD
Procainamide—BCHE—Metabolism—DPYD—endogenous depression	6.3e-05	0.000368	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1A—endogenous depression	6.3e-05	0.000367	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2C—endogenous depression	6.08e-05	0.000355	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OXT—endogenous depression	5.94e-05	0.000346	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CRH—endogenous depression	5.94e-05	0.000346	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CACNA1C—endogenous depression	5.86e-05	0.000342	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2D6—endogenous depression	5.74e-05	0.000335	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CACNB2—endogenous depression	5.72e-05	0.000334	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPH2—endogenous depression	5.72e-05	0.000334	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1A—endogenous depression	5.72e-05	0.000333	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—endogenous depression	5.64e-05	0.000329	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—DPYD—endogenous depression	5.63e-05	0.000328	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—COMT—endogenous depression	5.53e-05	0.000322	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2C—endogenous depression	5.52e-05	0.000322	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MAOA—endogenous depression	5.49e-05	0.00032	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—endogenous depression	5.46e-05	0.000318	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPH2—endogenous depression	5.33e-05	0.000311	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CACNB2—endogenous depression	5.33e-05	0.000311	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR7—endogenous depression	5.33e-05	0.000311	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—endogenous depression	5.27e-05	0.000307	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—DPYD—endogenous depression	5.25e-05	0.000306	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CACNA1C—endogenous depression	5.23e-05	0.000305	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2D6—endogenous depression	5.12e-05	0.000299	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CACNA1C—endogenous depression	4.88e-05	0.000285	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—endogenous depression	4.87e-05	0.000284	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR7—endogenous depression	4.84e-05	0.000282	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF2—endogenous depression	4.58e-05	0.000267	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2D6—endogenous depression	4.58e-05	0.000267	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF1—endogenous depression	4.39e-05	0.000256	CbGpPWpGaD
Procainamide—ACHE—Metabolism—COMT—endogenous depression	4.35e-05	0.000254	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MAOA—endogenous depression	4.32e-05	0.000252	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2D6—endogenous depression	4.26e-05	0.000249	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADM—endogenous depression	4.19e-05	0.000244	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPH1—endogenous depression	3.89e-05	0.000227	CbGpPWpGaD
Procainamide—BCHE—Metabolism—COMT—endogenous depression	3.88e-05	0.000226	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MAOA—endogenous depression	3.85e-05	0.000225	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—endogenous depression	3.73e-05	0.000218	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—endogenous depression	3.57e-05	0.000208	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OXT—endogenous depression	3.51e-05	0.000205	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CRH—endogenous depression	3.51e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—COMT—endogenous depression	3.47e-05	0.000202	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MAOA—endogenous depression	3.44e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—endogenous depression	3.39e-05	0.000198	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1A—endogenous depression	3.38e-05	0.000197	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—endogenous depression	3.26e-05	0.00019	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—COMT—endogenous depression	3.23e-05	0.000188	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MAOA—endogenous depression	3.21e-05	0.000187	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—endogenous depression	2.98e-05	0.000174	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPH2—endogenous depression	2.95e-05	0.000172	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNB2—endogenous depression	2.95e-05	0.000172	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DPYD—endogenous depression	2.9e-05	0.000169	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR7—endogenous depression	2.86e-05	0.000167	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—endogenous depression	2.81e-05	0.000164	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—endogenous depression	2.71e-05	0.000158	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.69e-05	0.000157	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—endogenous depression	2.51e-05	0.000146	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—endogenous depression	2.24e-05	0.000131	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—endogenous depression	2.09e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—endogenous depression	2e-05	0.000117	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—COMT—endogenous depression	1.79e-05	0.000104	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MAOA—endogenous depression	1.77e-05	0.000103	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—endogenous depression	1.6e-05	9.32e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—endogenous depression	1.15e-05	6.73e-05	CbGpPWpGaD
